53 related articles for article (PubMed ID: 37068643)
1. Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma.
Li F; Zhang J; Zhang J; Xue H; Liu L; Yang Z; Dong H; Wang K
Genomics; 2023 May; 115(3):110621. PubMed ID: 37068643
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
[TBL] [Abstract][Full Text] [Related]
3. Role of long non-coding RNAs in cholangiocarcinoma: A systematic review and meta-analysis.
Shobeiri P; Arabzadeh Bahri R; Khadembashiri MM; Khadembashiri MA; Maleki S; Eslami M; Khalili Dehkordi M; Behnoush AH; Rezaei N
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2029. PubMed ID: 38517409
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel hub genes and lncRNAs related to the prognosis and progression of pancreatic cancer by microarray and integrated bioinformatics analysis.
Liang X; Peng J; Chen D; Tang L; Liu A; Fu Z; Shi L; Wang K; Shao C
Gland Surg; 2021 Mar; 10(3):1104-1117. PubMed ID: 33842254
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a clinical prediction model for the risk of distal metastasis in intrahepatic cholangiocarcinoma: a real-world study.
Fang C; Xu C; Jia X; Li X; Yin C; Xing X; Li W; Wang Z
BMC Gastroenterol; 2024 Jan; 24(1):1. PubMed ID: 38166611
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the immunogenomic landscape of cholangiocarcinoma: Identifying new prognostic markers and therapeutic targets based on CCL5 expression.
Wang J; Xiang D; Dai Z; Zhu J; Du Y; Fu G; Chu X
J Gene Med; 2024 Jan; 26(1):e3630. PubMed ID: 37985959
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Basement Membrane Related LncRNA Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma.
Liu X; Lv C; Zheng J; Xiao J; He N; Du J; Yang X; Gu H
Biochem Genet; 2024 Apr; ():. PubMed ID: 38684626
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis the expression and clinical significance of CDRT15 in cholangiocarcinoma using TCGA database.
Yu T; Zhang T; Zhao L; Li K; Li J; Yu A
Medicine (Baltimore); 2023 Aug; 102(31):e34602. PubMed ID: 37543771
[TBL] [Abstract][Full Text] [Related]
9. M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1.
Li Z; Cao Z; Li N; Wang L; Fu C; Huo R; Xu G; Tian C; Bi J
Int J Nanomedicine; 2023; 18():5943-5960. PubMed ID: 37881607
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
Gao L; Lin Y; Yue P; Li S; Zhang Y; Mi N; Bai M; Fu W; Xia Z; Jiang N; Cao J; Yang M; Ma Y; Zhang F; Zhang C; Leung JW; He S; Yuan J; Meng W; Li X
BMC Med; 2023 Aug; 21(1):294. PubMed ID: 37553571
[TBL] [Abstract][Full Text] [Related]
11. Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review.
Chen Z; Guan D; Zhu Q; Wang Z; Han F; Zhou W
Curr Issues Mol Biol; 2023 Nov; 45(11):8864-8881. PubMed ID: 37998733
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders.
Ghasemian M; Rajabibazl M; Sahebi U; Sadeghi S; Maleki R; Hashemnia V; Mirfakhraie R
Cancer Cell Int; 2022 Jun; 22(1):215. PubMed ID: 35715800
[TBL] [Abstract][Full Text] [Related]
13. Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction.
Zhang C; Shen C
Medicine (Baltimore); 2023 Nov; 102(45):e35881. PubMed ID: 37960805
[TBL] [Abstract][Full Text] [Related]
14.
Torres-Llanos Y; Zabaleta J; Cruz-Rodriguez N; Quijano S; Guzmán PC; de Los Reyes I; Poveda-Garavito N; Infante A; Lopez-Kleine L; Combita AL
Front Mol Biosci; 2024; 11():1385140. PubMed ID: 38745909
[No Abstract] [Full Text] [Related]
15. Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma.
Zhang M; Liu Y; Kong D
J Bone Oncol; 2021 Feb; 26():100331. PubMed ID: 33376666
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma.
Da Z; Gao L; Su G; Yao J; Fu W; Zhang J; Zhang X; Pei Z; Yue P; Bai B; Lin Y; Meng W; Li X
Cancer Cell Int; 2020; 20():130. PubMed ID: 32336950
[TBL] [Abstract][Full Text] [Related]
17. BCL2L1 is regulated by the lncRNA MIR4435-2HG-miR-513a-5p-BCL2L1 ceRNA axis and serves as a biomarker for pancreatic adenocarcinoma treatment and prognosis.
Zhu R; Zhou H; Chen W; Bai S; Liu F; Wang X
Gene; 2024 May; 925():148615. PubMed ID: 38788819
[TBL] [Abstract][Full Text] [Related]
18. Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies.
Sato K; Glaser S; Francis H; Alpini G
Front Med (Lausanne); 2020; 7():48. PubMed ID: 32154257
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase A2 enzymes PLA2G2A and PLA2G12B as potential diagnostic and prognostic biomarkers in cholangiocarcinoma.
Qiu C; Xiang YK; Da XB; Zhang HL; Kong XY; Hou NZ; Zhang C; Tian FZ; Yang YL
World J Gastrointest Surg; 2024 Feb; 16(2):289-306. PubMed ID: 38463362
[TBL] [Abstract][Full Text] [Related]
20. lncRNAs are potential prognostic markers in patients with nasopharyngeal carcinoma in China: A systematic review and meta‑analysis.
Yu P; Ye J; Zhao S; Cai Y
Mol Clin Oncol; 2024 Feb; 20(2):11. PubMed ID: 38213659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
